内镜经蝶术后无功能垂体腺瘤的早期激素恢复
本研究纳入182例无症状无功能垂体腺瘤患者,均接受内镜经蝶手术并完整内分泌评估。术前68.1%存在至少一条轴激素功能障碍,术后1个月73.4%的患者至少一条轴改善,催乳素恢复率最高。
要点
- 术前68.1%的无症状无功能垂体腺瘤患者存在至少一条轴激素功能障碍。
- 术后1个月73.4%的激素功能障碍患者至少一条轴改善,催乳素恢复率最高。
- 术后短暂性尿崩与GH、ACTH恢复不良相关。
核心结论
- 无症状无功能垂体腺瘤的沉默性激素功能障碍常被忽视,有效手术减压后可改善,此类肿瘤可能是内镜经蝶手术的潜在指征。
研究设计与样本
- 单中心研究,纳入2014年3月至2018年12月182例无症状无功能垂体腺瘤患者,均行内镜经蝶手术及术前术后完整内分泌评估。
主要发现
- 124/182例(68.1%)术前至少一条轴激素功能障碍,其中61/124例(49.2%)为单轴、63例(50.8%)为两轴及以上。
- 中位内分泌随访15.0个月(6-57个月),术后1个月91例(73.4%)至少一条轴改善。
- 末次随访恢复率:催乳素92.8%、GH 50.0%、TSH 50.0%、Gn 46.9%、ACTH 45.0%。
- 恢复时间从催乳素1.1个月到Gn和ACTH 2.2个月不等。
- GH缺乏者术后短暂性尿崩与恢复不良相关(HR=0.50,p=0.048),ACTH缺乏者亦相关(HR=0.39,p=0.023)。
临床怎么用
- 对无症状无功能垂体腺瘤伴沉默性激素功能障碍者,可考虑内镜经蝶手术减压以促进激素恢复。
- 术后需规律内分泌随访,关注短暂性尿崩对GH、ACTH恢复的不良影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The role of transsphenoidal surgery in the recovery of preexisting hormone dysfunction from pituitary tumors remains controversial. This study aimed to investigate the incidence of hormone dysfunction among asymptomatic non-functioning pituitary adenomas and their recovery following endoscopic transsphenoidal surgery. METHODS: Eligibility criteria included age under 80 years, presence of a non-functioning pituitary adenoma compressing the normal gland resulting in deviation of the stalk, absence of visual symptoms, and availability for regular follow-up using MRI and pre- and post-operative endocrinological assessments. 182 patients with silent non-functioning pituitary adenomas were included in this study between March 2014 and December 2018. All patients underwent endoscopic transsphenoidal surgery and complete hormonal evaluation, with basal hormone assays and a combined pituitary function test before and after surgery until the end of last follow-up. RESULTS: Preoperative assessment of hormonal function revealed that 124 of 182 patients (68.1%) had at least a single hormone dysfunction preoperatively. Among these, 61 of 124 (49.2%) had a dysfunction in a single axis, and 63 (50.8%) had a hormone dysfunction in two or more axes. Overall, the median endocrinological follow-up duration was 15.0 months (6-57 months). At 1 month following surgery, 91 patients (73.4%) with hormone dysfunction experienced improvement in at least a single hormone axis. Prolactin was the most common hormone among those that recovered at the last follow up (92.8% improvement) followed by growth hormone (GH, 50.0%), thyroid stimulating hormone (TSH, 50.0%), gonadotropin (Gn, 46.9%), and adrenocorticotropic hormone (ACTH, 45.0%). Time to recovery varied from 1.1 months (for prolactin) to 2.2 months (for gonadotropin, and ACTH). In patients with preoperative deficiency in GH, and ACTH, postoperative transient diabetes insipidus was associated with poor recovery (GH: HR = 0.50, p = 0.048; ACTH: HR = 0.39, p = 0.023). CONCLUSIONS: Non-functioning pituitary adenomas with silent hormone dysfunction are often overlooked by clinicians and patients. We suggest that even silent hormone dysfunction in patients with non-functioning pituitary adenomas can be improved with effective surgical decompression and these tumors may be potential indications of endoscopic transsphenoidal surgery.
引用
- Lee MH, Hur KY, Hong SD, et al. Early hormonal recovery following endoscopic transsphenoidal surgery for silent non-functioning pituitary adenomas with hormone dysfunction. J Neurooncol. 2021. PMID: 34002303. doi:10.1007/s11060-021-03774-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。